Tada, T., Kurosaki, M., Tamaki, N., Yasui, Y., Mori, N., Tsuji, K., . . . Izumi, N. (2022). General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy. JGH open, 6(7), 487-495.
Chicago Style (17th ed.) CitationTada, Toshifumi, et al. "General Evaluation Score for Predicting the Development of Hepatocellular Carcinoma in Patients with Advanced Liver Fibrosis Associated with Hepatitis C Virus Genotype 1 or 2 After Direct‐acting Antiviral Therapy." JGH Open 6, no. 7 (2022): 487-495.
MLA (8th ed.) CitationTada, Toshifumi, et al. "General Evaluation Score for Predicting the Development of Hepatocellular Carcinoma in Patients with Advanced Liver Fibrosis Associated with Hepatitis C Virus Genotype 1 or 2 After Direct‐acting Antiviral Therapy." JGH Open, vol. 6, no. 7, 2022, pp. 487-495.
Visit our Citation Styles guide for help on properly citing sources.